Literature DB >> 7139538

Ovarian Sertoli-Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases.

J Prat, R H Young, R E Scully.   

Abstract

Twelve ovarian Sertoli-Leydig cell tumors that contained heterologous elements in the form of skeletal muscle (nine cases), cartilage (seven cases) and neuroblastoma (one case) in either the primary of recurrent specimens are reported. Four of the primary tumors also contained foci of gastrointestinal type epithelium with argentaffin cells identifiable in two of them. The age of the patients ranged from 11-48 years (average, 24 years). Ten patients presented with an abdominal mass, one with abdominal pain and one with acute abdominal symptoms. Five of the patients, two of whom were virilized and one of whom was hirsute, had evidence establishing or suggesting androgen overproduction. All the tumors were unilateral. Four had ruptured preoperatively and two ruptured during the operation. The tumors averaged 18.5 cm in greatest diameter and had extensive areas of hemorrhage and necrosis in half the cases. On microscopic examination the Sertoli-Leydig cell component was poorly differentiated in 11 cases and of intermediate differentiation in one case. In two cases the primary tumor was a poorly differentiated Sertoli-Leydig cell tumor and heterologous elements were identified only in a recurrent mass. Follow-up of ten patients revealed that eight of them had died of tumor from five months to seven years postoperatively.

Entities:  

Mesh:

Year:  1982        PMID: 7139538     DOI: 10.1002/1097-0142(19821201)50:11<2465::aid-cncr2820501135>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Ovarian tumors with functioning manifestations.

Authors:  Fattaneh A Tavassoli
Journal:  Endocr Pathol       Date:  1994-09       Impact factor: 3.943

2.  Endocrine pathology of the ovary : in tribute to Robert E Scully, MD.

Authors:  Esther Oliva; Robert H Young
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 3.  Sertoli-Leydig cell tumor with heterologous element: a case report and a review of the literature.

Authors:  Longwen Chen; Cairo Dana Tunnell; Giovanni De Petris
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

4.  Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.

Authors:  Hai-Yan Zhang; Jia-Er Zhu; Wen Huang; Jin Zhu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 5.  Hormone-producing tumors of the ovary.

Authors:  Ara Chalvardjian
Journal:  Endocr Pathol       Date:  1990-09       Impact factor: 3.943

6.  A case of Sertoli-Leydig cell tumour of the ovary with a multilocular cystic appearance on CT and MR imaging.

Authors:  Asako Azuma; Takashi Koyama; Yoshiki Mikami; Ken Tamai; Koji Fujimoto; Nobuko Morisawa; Fusaka Nagano; Shinya Yoshioka; Kaori Togashi
Journal:  Pediatr Radiol       Date:  2008-05-10

7.  An ovarian Sertoli-Leydig cell tumor with heterologous mucinous gland and NSE-immunoreactive-cell.

Authors:  N Arai; K Misugi; T Kamiya; S Shima
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

8.  Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.

Authors:  Sebastien Gouy; Alexandra Arfi; Amandine Maulard; Patricia Pautier; Enrica Bentivegna; Alexandra Leary; Cyrus Chargari; Catherine Genestie; Philippe Morice
Journal:  Oncologist       Date:  2018-09-10

9.  Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations.

Authors:  Jennifer A Bennett; Zehra Ordulu; Robert H Young; Andre Pinto; Koen Van de Vijver; Eike Burandt; Pankhuri Wanjari; Rajeev Shah; Leanne de Kock; William D Foulkes; W Glenn McCluggage; Lauren L Ritterhouse; Esther Oliva
Journal:  Mod Pathol       Date:  2021-05-20       Impact factor: 7.842

Review 10.  Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review.

Authors:  T Burnik Papler; S Frković Grazio; B Kobal
Journal:  J Ovarian Res       Date:  2016-07-30       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.